Histamine receptor antagonism and anti-tumour activity.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002927:Cimetidine / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D005663:Furans / Q000627:therapeutic use; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D008297:Male; D008785:Metiamide / Q000627:therapeutic use; D051379:Mice; D008815:Mice, Inbred Strains; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D011899:Ranitidine; D051381:Rats; D011919:Rats, Inbred Strains; D011929:Razoxane / Q000627:therapeutic use
D000970:Antineoplastic Agents; D005663:Furans; D006635:Histamine H2 Antagonists; D008785:Metiamide; D011929:Razoxane; D002927:Cimetidine; D011899:Ranitidine